-       Drug Pipelines 
- June 2025
-  200 Pages 
- Global 
   From       €2495EUR$2,789USD£2,194GBP 
            -       Report 
- December 2020
-  120 Pages 
- Global 
   From       €1431EUR$1,600USD£1,259GBP 
      €1789EUR$2,000USD£1,574GBP 
          -       Report 
- September 2024
-  100 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
            -       Report 
- March 2024
-  164 Pages 
- Global 
   From       €5689EUR$6,360USD£5,004GBP 
      €7111EUR$7,950USD£6,255GBP 
            -       Report 
- February 2024
-  245 Pages 
- Global 
   From       €5689EUR$6,360USD£5,004GBP 
      €7111EUR$7,950USD£6,255GBP 
             -       Report 
- February 2023
-  120 Pages 
- Global 
   From       €5367EUR$6,000USD£4,721GBP 
      €6708EUR$7,500USD£5,901GBP 
            -       Report 
- February 2023
-  60 Pages 
- Global 
   From       €2826EUR$3,160USD£2,486GBP 
      €3533EUR$3,950USD£3,108GBP 
            -       Report 
- September 2022
-  239 Pages 
- Global 
   From       €5367EUR$6,000USD£4,721GBP 
      €6708EUR$7,500USD£5,901GBP 
          -       Report 
- February 2024
-  204 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
          -       Report 
- February 2024
-  112 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
          -       Report 
- April 2023
-  117 Pages 
- Global 
   From       €4249EUR$4,750USD£3,737GBP 
            -       Report 
- May 2024
-  139 Pages 
- Global 
   From       €4941EUR$5,524USD£4,346GBP 
      €5813EUR$6,499USD£5,113GBP 
          -       Report 
- April 2023
-  326 Pages 
- Global 
   From       €3220EUR$3,600USD£2,832GBP 
          -       Report 
- August 2024
-  150 Pages 
- Global 
   From       €2495EUR$2,789USD£2,194GBP 
          -       Report 
- August 2024
-  150 Pages 
- Global 
   From       €2495EUR$2,789USD£2,194GBP 
          -       Report 
- September 2024
-  239 Pages 
- China 
   From       €3578EUR$4,000USD£3,147GBP 
          -       Report 
- September 2024
-  69 Pages 
- China 
   From       €1610EUR$1,800USD£1,416GBP 
          -       Report 
- February 2024
-  96 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- August 2023
-  78 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
          -       Report 
- July 2023
-  84 Pages 
- Global 
   From       €3500EUR$4,192USD£3,186GBP 
       
      Fluorouracil (5-FU) is a chemotherapy drug used in the treatment of cancer. It is a pyrimidine analog, which interferes with the synthesis of DNA and RNA, leading to cell death. It is used to treat a variety of cancers, including breast, colorectal, gastric, pancreatic, and head and neck cancers. It is also used in combination with other drugs to treat advanced or metastatic cancers. Fluorouracil is administered intravenously or topically, depending on the type of cancer being treated.
Fluorouracil    is a widely used drug in the oncology market, and is often used in combination with other drugs to treat advanced or metastatic cancers. It is a generic drug, and is available in both branded and generic formulations. The branded formulations are typically more expensive than the generic versions.
Companies in the Fluorouracil market include Pfizer, Merck, Bristol-Myers Squibb, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less   Read more